Cambridge health tech firm Qureight has appointed former Riverlane executive Rebecca Simmons (pictured) as its new chief operating officer.
Simmons has been tasked with scaling the AI CT imaging company’s global business operations.
The new Qureight COO previously held the same role at Riverlane, a prominent player in quantum error correction technology. In her time at the firm she helped oversee its growth from a team of 10 to more than 100 as well as playing a key role in the securing of more than £100m in funding.
“Qureight’s pioneering AI-powered CT imaging biomarkers and data management platform is enabling real insights to be drawn from complex and diverse health data, to ultimately deliver real impact for patients,” said Simmons.
“The team is already incredible, with an expert team of clinicians, scientists and machine learning engineers. I’m delighted to join the company and am looking forward to an exciting year!”
The medtech company raised more than £6m in a Series A funding round in 2024.
“Rebecca’s experience, expertise and people-centric leadership approach will be instrumental in supporting the team as we scale the company, accelerating our mission to advance the understanding of lung and heart disease,” said Qureight co-founder and chief executive Muhunthan Thillai.
“Her blend of rigorous academic training with commercial acumen made Rebecca the natural choice to lead this next chapter of growth for Qureight. Welcome to the team, Rebecca.”
Read more: Qureight founder: Pitching to investors is energising once you take the plunge
